The consortium’s central message is that the intestinal stem cell is not a fixed identity but a flexible state dictated by its surroundings. Historically, researchers divided intestinal stem cells into two camps: actively self-renewing cells marked by the gene Lgr5, which continuously fuel the everyday turnover of the epithelium, and a facultative or ‘reserve’ population, sometimes called revival stem cells, that normally rests but springs into action after catastrophic injury. Landmark studies identified Bmi1, Hopx, and other markers for these reserve cells, and work by Tian and colleagues showed that a reserve population could render Lgr5-positive cells dispensable under certain conditions. The new Roadmap argues that neither population is intrinsically determined; rather, homeostatic and regenerative properties emerge from signals emanating from a specialized local niche, the microenvironment that cradles the stem cells and instructs their behavior.

That niche has turned out to be far more complex than early models suggested. In the small intestine, Paneth cells interdigitated among the stem cells at the crypt base supply Wnt ligands, antimicrobial peptides, and metabolic support, although studies by Kim, Escudero, and Shivdasani demonstrated that Lgr5 stem cells can function even without Paneth cells, pointing to redundant support systems. Surrounding the crypts lies a constellation of mesenchymal cell types, each with distinct jobs. PDGFRα-positive pericryptal stromal cells and GLI1-expressing cells serve as critical sources of Wnts and the Wnt-amplifying protein RSPO3, while FOXL1-positive telocytes, CD34-positive mesenchymal cells, and distinct smooth muscle layers contribute additional Wnt ligands, bone morphogenetic protein gradients, and structural organization. Graded BMP signaling within the crypt architecture, as shown by Kraiczy and colleagues, even directs the self-organization of the Wnt-secreting niche itself, revealing an intricate feedback loop between epithelium and stroma.

Beyond fibroblasts, the consortium highlights an expanding cast of niche regulators. Lymphatic vessels act as signaling hubs, with lymphangiocrine signals required for proper repair after cytotoxic injury. Enteric glial cells, macrophages, and type 3 innate lymphoid cells all modulate stem cell activity, the latter through the cytokine interleukin-22, which promotes stem-cell-mediated epithelial regeneration and protects stem cells from immune-mediated damage. Even nerves participate: adrenergic nerves regulate intestinal regeneration through IL-22 signaling from innate lymphoid cells, and nociceptive neurons have been implicated in tumor progression via a CGRP-RAMP1 axis. Mechanosensing adds another dimension, with PIEZO-dependent mechanical signals proving essential for stem cell fate decisions. The picture that emerges is of a layered, multi-tissue ecosystem in which epithelial, mesenchymal, immune, vascular, lymphatic, and neural components jointly govern when stem cells divide, differentiate, or revert to a fetal-like regenerative program.

Cellular plasticity sits at the heart of this regenerative capacity. When Lgr5-positive stem cells are ablated, a remarkable variety of differentiated and progenitor cells can dedifferentiate and rebuild the stem cell compartment. Dll1-positive secretory progenitors, enterocyte-lineage daughters, Paneth cells responding to Notch activation, enteroendocrine lineage cells, and even tuft cells, which Huang and colleagues showed act as regenerative stem cells in the human intestine, have all been documented to revert. Single-cell transcriptomics revealed a revival stem cell state marked by fetal programs, and parasitic helminths were found to induce fetal-like reversion in the niche as part of the immune response. Chromatin studies explain how this is possible: the intestinal epithelium maintains broadly permissive chromatin that allows rapid switching between lineages, while factors such as Ascl2, ATOH1 phosphorylation, and Frizzled5-controlled chromatin accessibility orchestrate the dedifferentiation process. In disease, this plasticity is a double-edged sword, since the same reserve and revival programs that heal wounds can seed radioresistant, cancer-initiating populations.

Translating this biology into therapies has been propelled by organoid technology, one of the field’s transformative breakthroughs. In 2009, Sato and colleagues showed that single Lgr5 stem cells could build crypt-villus structures in vitro without a mesenchymal niche, and Ootani’s team sustained intestinal epithelium in a Wnt-dependent stem cell culture system the same year. Human colon, adenoma, and Barrett’s epithelium organoids followed in 2011, as did the directed differentiation of human pluripotent stem cells into intestinal tissue by Spence and colleagues. The technology has since matured dramatically: scaffold-guided morphogenesis produces homeostatic mini-intestines, organoid-derived tissues have repaired damaged bowel in vivo, patient-derived jejunal mucosal grafts have been engineered from children with intestinal failure, and organ-repurposing approaches have treated short bowel syndrome in preclinical models. Human intestinal organoids transplanted into humanized mice develop immune tissue, and coordinated differentiation protocols now generate organoids with functional enteric neurons and vasculature, bringing engineered gut tissue closer to clinical reality.

The consortium also emphasizes how organoids and microfluidic gut-on-a-chip systems have become indispensable for studying host-pathogen interactions. Complex human gut microbiomes have been cultured in anaerobic intestine-on-a-chip devices, and human colon models have revealed uncoupled apical and basal cytotoxicity during early Clostridioides difficile toxin exposure. These platforms allow researchers to interrogate how pathogens reshape the stem cell compartment and how microbial metabolites, such as microbiota-derived lactate, accelerate stem-cell-mediated epithelial development. Innate immune receptors on the stem cells themselves, including Toll-like receptor 4 and NOD2, which protects LGR5-positive cells from reactive oxygen species through mitophagy, directly link microbial sensing to regenerative capacity, suggesting that microbiome manipulation could become a therapeutic lever for mucosal healing.

Pharmacological strategies form the second pillar of the therapeutic roadmap. R-spondin ligands, potent amplifiers of Wnt signaling, have been shown to induce intestinal stem cells, augment chemoradioprotection, promote colonic regeneration, and ameliorate experimental colitis, while surrogate Wnt agonists that phenocopy canonical signaling support organoid growth and show promise for FZD-specific activation of repair pathways. Glucagon-like peptide-2 agonists, already approved for short bowel syndrome, stimulate S-phase entry of Lgr5-positive stem cells and support stem cell and Paneth cell repair during graft-versus-host disease, with newer agents such as glepaglutide showing anti-inflammatory and mucosal regenerative effects. Structure-based design has even decoupled the tissue-protective functions of interleukin-22 from its pro-inflammatory actions, opening the door to safer regenerative cytokine therapies. The consortium cautions, however, that stimulating proliferation carries oncogenic risk, and that niche dysregulation is predicted to underlie compromised regeneration in conditions such as inflammatory bowel disease, where stem cells retain epigenetic memories of inflammation.

The Roadmap closes with a candid inventory of remaining knowledge gaps. Human intestinal stem cells differ from their mouse counterparts in ways that matter for therapy, and spatial atlases of the adult human intestine, single-cell maps of human development, and spatial transcriptomic surveys of regeneration are only now filling the void. Bioengineered colon organoids with in vivo-like complexity, bioprinted tissues recapitulating macro-scale self-organization, and instant collagen assembly for tissue engineering are pushing manufacturing capabilities forward, while lessons from the first pluripotent stem cell therapies entering the clinic, including stem-cell-derived islets for diabetes and retinal cells for macular degeneration, offer a template for regulatory and safety pathways. What the ISCC’s fifteen-year arc demonstrates is that the intestine, once considered too dynamic and complex to rebuild, has yielded its construction secrets to systematic, collaborative biology. The remaining challenge is engineering: assembling niche cells, immune compartments, vasculature, and nerves into transplantable tissue that can survive, integrate, and function in patients whose own guts can no longer keep pace. If the consortium’s roadmap holds, the era of stem-cell-built intestines may be closer than anyone dared predict when the effort began.

Subject of Research: Intestinal stem cell biology and stem cell-based strategies for intestinal regeneration and tissue engineering

Article Title: Building and regenerating intestines by manipulating intestinal stem cells

Article References: Building and regenerating intestines by manipulating intestinal stem cells. (n.d.). https://doi.org/10.1038/s41575-026-01242-4

Image Credits: AI Generated

DOI: 10.1038/s41575-026-01242-4

Keywords: intestinal stem cells, stem cell niche, organoids, epithelial regeneration, Wnt signaling, R-spondin, interleukin-22, cellular plasticity, short bowel syndrome, inflammatory bowel disease, tissue engineering, Intestinal Stem Cell Consortium

The discovery centers on reactive oxygen species, a family of chemically reactive molecules that were once dismissed as dangerous metabolic byproducts. Over the past two decades, biologists working on organisms from fruit flies to flowering plants have come to appreciate that certain reactive oxygen species act as genuine signals, capable of steering cells toward one developmental fate or another. In plant meristems, the two most prominent members of this family, the superoxide anion and hydrogen peroxide, occupy distinctly different territories. Earlier work in the model plant Arabidopsis showed that superoxide accumulates in the central zone of the meristem, where it helps preserve stem cell identity, partly by influencing epigenetic marks such as DNA methylation on target genes. Hydrogen peroxide, by contrast, gathers in the peripheral zone where new organs initiate, where it appears to nudge cells toward differentiation. This spatial segregation turns the meristem into a kind of chemical map, with each reactive oxygen species marking a different developmental region.

What remained unclear was how plants maintain such a carefully patterned distribution of reactive molecules, particularly in crop species. The Chinese team approached the question through maize, a staple cereal whose yield and architecture depend directly on how well its meristems perform. Their attention fell on MSCA1, a CC-type glutaredoxin that the group had previously shown to regulate meristem size, together with its two close relatives ZmGRX2 and ZmGRX5. Glutaredoxins are small oxidoreductase enzymes that modify the redox state of specific cysteine residues on target proteins, and the researchers wanted to know whether these proteins directly shape the reactive oxygen landscape of the meristem rather than merely acting on transcription factors downstream.

To find out, the team assembled a collection of maize mutants carrying disruptions in one, two, or all three of the glutaredoxin genes, all generated in the standard B73 inbred background and grown under controlled greenhouse conditions at Sun Yat-Sen University in Shenzhen. When the researchers measured seedlings fourteen days after germination, a clear pattern emerged. Plants carrying mutations in both msca1 and zmgrx5 were noticeably shorter than their wild-type counterparts, and the triple mutant showed the strongest reduction. Dissection and microscopic measurement of the shoot tips revealed that meristem width and height shrank progressively as more glutaredoxin genes were lost, indicating that the three genes act redundantly to promote meristem development, with MSCA1 and ZmGRX5 shouldering most of the burden. RNA in situ hybridization placed the three genes in leaf primordia initiation sites and developing vascular tissues, precisely the regions where new organs begin their lives.

The transcriptome of the triple mutant told a striking molecular story. RNA sequencing of meristem tissue identified 4,248 differentially expressed genes relative to wild type, with 2,714 genes up-regulated and 1,534 down-regulated. While the down-regulated genes were enriched mainly for basic cellular activities and developmental processes, consistent with the growth defects, the up-regulated genes were heavily concentrated in reactive oxygen related pathways. This transcriptional reprogramming hinted that losing the glutaredoxin module throws the redox machinery of the meristem into disarray. The researchers then turned to a classic histochemical technique, staining seedlings with nitroblue tetrazolium, a compound that precipitates in the presence of superoxide. In wild-type meristems, the stain concentrated in the central zone, confirming that superoxide occupies the stem cell heart of the maize meristem just as it does in Arabidopsis. In the double and triple mutants, that signal faded dramatically, and the degree of fading tracked with the shrinking meristem size.

Pharmacological experiments reinforced the connection between redox state and meristem growth. Treating seedlings with two broad-spectrum radical scavengers, n-propyl gallate and N,N’-dimethylthiourea, reduced meristem size in both wild-type plants and glutaredoxin mutants. The authors are careful to note that these chemicals are not superoxide-specific, so the treatments should be read as perturbations of the general redox environment rather than as precise depletion of a single species. Even so, the results support the broader conclusion that meristem development demands a properly balanced redox state, and that the spatial enrichment of superoxide in the central zone is a feature worth defending.

The search for the molecular mechanism led the team through the maize genome’s repertoire of reactive oxygen metabolism genes. From an initial list of 37 annotated candidates, filtered by tissue-specific transcriptomic data and subcellular localization predictions confirmed in tobacco leaves, the researchers narrowed the field to 16 enzymes for protein interaction screening. Yeast two-hybrid assays identified two superoxide dismutases, ZmCSD5 and ZmMSD2, as interaction partners of MSCA1, and the physical association with ZmCSD5 was independently confirmed by luciferase complementation imaging and bimolecular fluorescence complementation in Nicotiana benthamiana leaves. The choice to prioritize ZmCSD5 for deeper analysis rested on a biochemical rationale: glutaredoxins typically regulate targets through cysteine-dependent thiol modifications, and while ZmMSD2 lacks cysteine residues entirely, ZmCSD5 carries two highly conserved cysteines, at positions 119 and 208, that offer a plausible handle for redox regulation. The authors emphasize that direct modification of these residues by MSCA1 has not yet been demonstrated, leaving an important biochemical question open.

Genetic evidence, however, lined up neatly with the proposed model. Total superoxide dismutase activity was significantly elevated in both the msca1 single mutant and the triple mutant compared with wild type, exactly what one would expect if the glutaredoxin module normally restrains the scavenging enzyme. When the researchers used CRISPR-Cas9 to knock out ZmCSD5, generating frameshift alleles that likely represent null mutations upstream of the conserved copper-zinc superoxide dismutase domain, the resulting plants developed significantly enlarged meristems, the mirror image of the shrunken meristems seen in the glutaredoxin mutants. In situ hybridization showed that ZmCSD5 is expressed throughout the meristem and developing leaf primordia, overlapping with the expression domains of the three glutaredoxin genes. Taken together, these results cast ZmCSD5 as a negative regulator of meristem development and support a working model in which MSCA1 binds to ZmCSD5 and restrains its activity, limiting excessive superoxide scavenging in the central zone and thereby preserving the localized superoxide pool that stem cells require. Because genetic epistasis between MSCA1 and ZmCSD5 has not yet been tested, the authors acknowledge that constructing double mutants will be an important next step to firmly establish the hierarchy.

The findings also complete a broader picture of how glutaredoxins govern maize development. Earlier work from the same group showed that MSCA1 modulates the DNA-binding activity of the bZIP transcription factor FEA4 through redox modification, tuning the transcriptional network that shapes inflorescence architecture. The new study adds an upstream role: the glutaredoxin module maintains the chemical microenvironment, specifically superoxide homeostasis, in which such redox-sensitive targets operate. This dual action, intervening simultaneously in metabolic homeostasis and in downstream transcriptional responses, positions these three glutaredoxins as central hubs of the redox regulatory network controlling maize morphogenesis. Beyond its fundamental interest, the work carries practical weight. Meristem size influences the number of organs a plant can initiate, and ultimately traits such as yield, so the MSCA1-ZmCSD5 module offers plant breeders and molecular biologists a concrete genetic target. As the climate places new stresses on staple crops, understanding how a plant guards the tiny chemical gradient at its growing tip may prove to be one of the more consequential lessons of modern crop science.

Subject of Research: A GRX-SOD redox regulatory module that maintains superoxide homeostasis and shoot apical meristem development in maize.

Article Title: A GRX-SOD module maintains superoxide homeostasis and meristem development in maize

Article References: Guo, T., Liu, X., Yang, R., Wang, Y., & Yang, F. (2026). A GRX-SOD module maintains superoxide homeostasis and meristem development in maize. Advanced Biotechnology, 4(3), Article 36. https://doi.org/10.1007/s44307-026-00133-8

Image Credits: AI Generated

DOI: 10.1007/s44307-026-00133-8

Keywords: maize, shoot apical meristem, glutaredoxin, superoxide dismutase, reactive oxygen species, superoxide homeostasis, MSCA1, ZmCSD5, stem cell niche, plant architecture, redox regulation, CRISPR-Cas9